Understanding the remaining unmet needs in a post ASCT NDMM setting

Approaches to risk stratification in high risk myeloma

Use of bispecifics and CAR T cells in South America

Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM

Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients

Guiding transplant decisions in multiple myeloma with MRD

Revolutionising multiple myeloma treatment with CAR T-Cell therapies

Legislation – a powerful tool for promoting massive changes

Gaza's cancer patients: Navigating the dual struggle of illness and war

Tackling breast cancer screening in conservative communities

Cooperative training for medical staff in Côte d'Ivoire: The national radiotherapy and medical oncology center project

Post-diagnosis diet, nutrition and cancer prognosis